By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Conditions A-Z > Endocrine > Type 2 Diabetes

Type 2 Diabetes

GMJ
Last updated: 02/06/2026 14:31
By
Prof. Giorgi Pkhakadze
Share
6 Min Read
SHARE
4 min read|773 words

Type 2 Diabetes

What is Type 2 Diabetes?

Type 2 diabetes is a chronic metabolic disorder characterized by insulin resistance and relative insulin deficiency, leading to persistently elevated blood glucose levels. Unlike type 1 diabetes, the pancreas continues to produce insulin, but the body’s cells become resistant to its effects, and insulin production may gradually decline over time. This condition affects people of all ages but is most commonly diagnosed in adults over 45. Type 2 diabetes accounts for approximately 90-95% of all diabetes cases worldwide, making it one of the most prevalent chronic diseases globally.

Key statistics

Global prevalence 422 million people worldwide
Adults affected 1 in 10 adults (20-79 years)
Annual deaths 1.5 million directly attributed to diabetes
Typical age of onset 45+ years (increasingly affecting younger adults)

Symptoms

Common early symptoms: Increased thirst, frequent urination, fatigue, blurred vision, slow-healing wounds, increased hunger, unexplained weight loss.

Type 2 diabetes often develops gradually, and many people may have the condition for years before symptoms become noticeable. Increased thirst and frequent urination occur as the kidneys work overtime to filter excess glucose from the blood. Fatigue results from cells being unable to effectively use glucose for energy. Blurred vision happens when high blood sugar causes the lens of the eye to swell. Slow-healing wounds and frequent infections occur because high glucose levels impair immune function and blood circulation. Some people experience tingling or numbness in hands and feet due to nerve damage. Dark patches of skin (acanthosis nigricans) may appear in body folds, particularly around the neck and armpits.

Causes and risk factors

Type 2 diabetes results from a combination of genetic predisposition and environmental factors. The primary mechanism involves insulin resistance, where cells in muscle, fat, and liver don’t respond effectively to insulin, combined with the pancreas’s inability to produce enough insulin to overcome this resistance.

Submit Your Paper
GMJ_Submit_Banner

Genetic factors: Family history significantly increases risk, with multiple genes contributing to susceptibility. Having a parent or sibling with type 2 diabetes doubles the risk.

Environmental and lifestyle risk factors include: Obesity (especially abdominal fat), physical inactivity, poor diet high in processed foods and added sugars, age over 45, high blood pressure, abnormal cholesterol levels, history of gestational diabetes, polycystic ovary syndrome (PCOS), and certain ethnicities (African American, Hispanic, Native American, Asian American, Pacific Islander populations have higher risk).

Prevention

Type 2 diabetes is largely preventable through lifestyle modifications. The Diabetes Prevention Program demonstrated that intensive lifestyle changes can reduce diabetes risk by 58% in high-risk individuals.

Evidence-based prevention strategies include: Maintaining a healthy weight (losing 5-10% of body weight if overweight), engaging in at least 150 minutes of moderate-intensity aerobic activity weekly, following a balanced diet rich in whole grains, vegetables, lean proteins, and healthy fats while limiting processed foods and sugary beverages, and avoiding tobacco use.

Screening recommendations: Adults aged 35-70 who are overweight should be screened every three years. Earlier and more frequent screening is recommended for those with additional risk factors, including family history, high-risk ethnicity, history of gestational diabetes, or metabolic syndrome components.

Complications

Untreated or poorly controlled type 2 diabetes can lead to serious complications affecting multiple organ systems. Cardiovascular disease is the leading cause of death, with diabetes increasing heart disease and stroke risk by 2-4 times. Diabetic nephropathy can progress to kidney failure requiring dialysis or transplantation. Diabetic retinopathy may cause vision loss and blindness. Diabetic neuropathy can lead to pain, numbness, and in severe cases, amputations. Other complications include delayed wound healing, increased infection risk, hearing impairment, sleep apnea, and increased risk of dementia and depression.

Diagnosis

Type 2 diabetes diagnosis relies on blood glucose measurements. Fasting plasma glucose ≥126 mg/dL (7.0 mmol/L) after 8-hour fast, hemoglobin A1C ≥6.5% (48 mmol/mol), oral glucose tolerance test with 2-hour glucose ≥200 mg/dL (11.1 mmol/L), or random plasma glucose ≥200 mg/dL with classic symptoms confirms diagnosis. The A1C test is preferred due to convenience and reflects average blood glucose over 2-3 months. Prediabetes is diagnosed with fasting glucose 100-125 mg/dL or A1C 5.7-6.4%, indicating increased diabetes risk.

Treatment

Treatment aims to achieve and maintain target blood glucose levels while preventing complications. Lifestyle modifications remain the cornerstone, including medical nutrition therapy and regular physical activity.

Medications are often necessary and include: metformin as first-line therapy, which reduces glucose production and improves insulin sensitivity. Second-line options include sulfonylureas, SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and insulin when oral medications are insufficient.

Blood pressure and cholesterol management are crucial, often requiring ACE inhibitors or statins. Regular monitoring includes A1C every 3-6 months, annual eye and kidney function exams, and daily blood glucose checking for those on insulin.

Prognosis

With proper management, people with type 2 diabetes can live long, healthy lives with minimal complications. Good glycemic control (A1C Quality of life

Living well with type 2 diabetes requires ongoing self-management and lifestyle adaptations. Daily blood glucose monitoring helps guide food choices and medication timing. Meal planning focuses on consistent carbohydrate intake, portion control, and choosing low glycemic index foods. Regular physical activity improves glucose control and overall health – even 10-minute walks after meals can help.

Stress management is crucial as stress hormones can raise blood glucose. Techniques include meditation, yoga, or counseling. Sleep quality affects glucose control, making 7-9 hours of quality sleep important. Foot care prevents complications through daily inspection and proper footwear. Many people find diabetes education classes and support groups helpful for motivation and practical tips.

Pregnancy and fertility

Type 2 diabetes can affect fertility in both men and women and requires careful management during pregnancy. Preconception planning is essential, with target A1C Gestational complications include increased risk of miscarriage, preeclampsia, preterm delivery, and macrosomia (large baby). Women with diabetes should receive specialized obstetric care and frequent monitoring. Breastfeeding is encouraged and may help prevent type 2 diabetes in children.

Children

Type 2 diabetes in children and adolescents is increasing, often associated with childhood obesity. Presentation may be similar to adults but can progress more rapidly. Family involvement is crucial for successful management, including meal planning and activity promotion. School accommodations may include blood glucose monitoring, medication administration, and snack provisions. Transition planning to adult care typically begins around age 16-18, emphasizing self-management skills development and healthcare provider relationships.

When to see a doctor

Seek immediate medical attention for severe hyperglycemia symptoms including persistent vomiting, dehydration, confusion, difficulty breathing, or blood glucose >400 mg/dL. Urgent care is needed for signs of diabetic ketoacidosis (though rare in type 2), severe hypoglycemia, infected wounds, or chest pain. Routine monitoring includes quarterly visits for A1C checks, annual comprehensive exams including eye and foot examinations, and more frequent visits when starting new medications or experiencing control difficulties.

Regional context

Limited specific data exists for type 2 diabetes prevalence in the Caucasus region, though Eastern Mediterranean countries show increasing rates similar to global trends. Georgia has reported rising diabetes prevalence, particularly in urban areas. Healthcare infrastructure varies across the region, with ongoing efforts to improve diabetes education and management programs. GMJ welcomes contributions from regional researchers to build the evidence base for type 2 diabetes in the Caucasus.

Research and clinical trials

Current research focuses on personalized medicine approaches, novel drug targets, and diabetes prevention strategies. Emerging therapies include dual GLP-1/GIP receptor agonists, smart insulin formulations, and beta-cell regeneration techniques. Technology advancement in continuous glucose monitoring and insulin delivery systems improves management options. Prevention studies examine lifestyle interventions and medications for high-risk populations. Patients can find clinical trials at ClinicalTrials.gov, particularly for new medications and management technologies.

Frequently asked questions

Can type 2 diabetes be reversed?

While type 2 diabetes is considered a chronic condition, some people achieve remission through significant weight loss, intensive lifestyle changes, or bariatric surgery. However, continued monitoring and lifestyle maintenance are necessary to prevent recurrence.

How often should I check my blood sugar?

Frequency depends on treatment type and glucose control. People taking insulin may need multiple daily checks, while those on oral medications might check 2-3 times weekly or as directed by their healthcare provider.

What foods should I avoid completely?

No foods are completely forbidden, but portions and timing matter. Focus on limiting refined sugars, processed foods, and large portions of high-carbohydrate foods rather than complete elimination.

Will I definitely need insulin eventually?

Not necessarily. Many people manage type 2 diabetes long-term with oral medications and lifestyle changes. However, because the condition can be progressive, some people may eventually benefit from insulin therapy.

Can stress really affect my blood sugar?

Yes, stress hormones like cortisol can raise blood glucose levels. Chronic stress may also affect eating habits and medication adherence, indirectly impacting glucose control.

Support and resources

International organizations:
– International Diabetes Federation (idf.org)
– American Diabetes Association (diabetes.org)
– Diabetes UK (diabetes.org.uk)
– World Health Organization Diabetes Programme (who.int)
– European Association for the Study of Diabetes (easd.org)
– Juvenile Diabetes Research Foundation (jdrf.org)

Online communities provide peer support and practical advice for daily diabetes management challenges.

Related conditions

Type 1 diabetes – Autoimmune destruction of insulin-producing cells requiring insulin therapy from diagnosis.

Metabolic syndrome – Cluster of conditions including insulin resistance, obesity, and hypertension that increase diabetes risk.

Prediabetes – Elevated blood glucose levels that don’t yet meet diabetes criteria but indicate high progression risk.

Gestational diabetes – Diabetes developing during pregnancy that increases future type 2 diabetes risk.

Diabetic nephropathy – Kidney damage resulting from prolonged high blood glucose levels.

Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, UpToDate, relevant EULAR/ACR/WHO guidelines. This article is for informational purposes only and does not constitute medical advice. Content licensed under CC BY 4.0.

Cite this page

GMJ News Desk. “Type 2 Diabetes.” GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/condition/type-2-diabetes-2/

CC BY 4.0Licensed under CC BY 4.0. Free to share with attribution to GMJ News.

Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, EULAR/ACR guidelines. Schema.org MedicalCondition structured data included.

Was this article helpful?

Related topics

Optional further reading from the GMJ knowledge base.

In the news
Eight Common Food Additives Linked to Hypertension and Cardiovascular Disease in Large Cohort Study GLP-1 Drugs Linked to Lower Violent Behaviour in Rutgers Study Oral GLP-1 medication shows major promise for type 2 diabetes: weight loss and blood sugar control in pivotal trial
In the news
  • Eight Common Food Additives Linked to Hypertension and Cardiovascular Disease in Large Cohort Study · Jul 13, 2026
  • GLP-1 Drugs Linked to Lower Violent Behaviour in Rutgers Study · Jul 11, 2026
  • Oral GLP-1 medication shows major promise for type 2 diabetes: weight loss and blood sugar control in pivotal trial · Jul 11, 2026
  • Return migrants in sub-Saharan Africa face persistent health barriers despite homecoming, scoping review finds · Jul 11, 2026
  • Native Hawaiian Adults Face Mobility Decline Years Earlier Than Peers · Jul 10, 2026
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
UK Updates Influenza Vaccine Delivery Framework for 2024–25 Seasonal Campaign

The UK Department of Health and Social Care has released an updated…

England’s Euro 2024 Match Days Saw 17,000 Fewer A&E Visits — Why That Matters for Health Planning

Analysis of NHS accident and emergency data from Euro 2024 reveals just…

Americas Health Leadership: PAHO Executive Committee Endorses Plan to Strengthen Regional Health Systems

The Pan American Health Organization Executive Committee endorsed a comprehensive strategic framework…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Type 1 Diabetes

By
Prof. Giorgi Pkhakadze
01/06/2026

Bardet-Biedl syndrome

By
Prof. Giorgi Pkhakadze
02/06/2026

Tay-Sachs disease

By
Prof. Giorgi Pkhakadze
02/06/2026

Acute intermittent porphyria

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up